Trial Details
UNKNOWNBasic Information
| Clinical ID | c3057 |
|---|---|
| Identifier | NCT02580617 |
| Trial Title | A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: ALLO-ASC |
Participant Information
| Sponsor | Anterogen Co., Ltd. |
|---|---|
| City | Seoul |
| Country/Region | South Korea |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2015-11-09 |
|---|---|
| Primary Completion Date | 2023-12 |
| Completion Date | 2023-12 |